139 related articles for article (PubMed ID: 37986346)
1. Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.
Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of ALK and CD30 expression in mature systemic T cell lymphomas: analysis from the Czech Lymphoma Study Group database (NIHIL).
Janikova A; Michalka J; Chloupkova R; Kopalova N; Campr V; Kamaradova K; Kren L; Belada D; Benesova K; Dlouha J; Klener P; Procházka V; Mocikova H; Duras J; Trneny M
Ann Hematol; 2022 Apr; 101(4):789-798. PubMed ID: 35061088
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
[TBL] [Abstract][Full Text] [Related]
5. High intratumoural galectin-1 expression predicts adverse outcome in ALK
Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
7. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
[TBL] [Abstract][Full Text] [Related]
8.
Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P
Haematologica; 2021 Nov; 106(11):2918-2926. PubMed ID: 33054126
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of peripheral T-cell lymphomas.
Piccaluga PP; Tabanelli V; Pileri SA
Int J Hematol; 2014 Mar; 99(3):219-26. PubMed ID: 24481943
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of mature T-cell and NK-cell lymphoma with CD30 expression based on latest WHO classification].
Feng Y; Fu J; Yan S; Ling Y; Huang Y; Cai M; Rao H
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):508-11. PubMed ID: 25346118
[TBL] [Abstract][Full Text] [Related]
13. Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells.
Fujishima F; Fukuhara N; Katsushima H; Nakamura Y; Harigae H; Sasano H; Ichinohasama R
BMC Cancer; 2021 Dec; 21(1):1352. PubMed ID: 34930176
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
16. Differential diagnosis and identification of prognostic markers for peripheral T-cell lymphoma subtypes based on flow cytometry immunophenotype profiles.
Pu Q; Qiao J; Liu Y; Cao X; Tan R; Yan D; Wang X; Li J; Yue B
Front Immunol; 2022; 13():1008695. PubMed ID: 36466894
[TBL] [Abstract][Full Text] [Related]
17. [T-bet in peripheral T-cell lymphoma].
Wang Z; Zhang DB; Zhou W
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):779-783. PubMed ID: 27719721
[TBL] [Abstract][Full Text] [Related]
18. JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology.
Fitzpatrick MJ; Massoth LR; Marcus C; Vergilio JA; Severson E; Duncan D; Ramkissoon SH; Hasserjian RP; Kim AS; Sohani AR; Williams EA; Nardi V
Am J Surg Pathol; 2021 Jul; 45(7):895-904. PubMed ID: 34105517
[TBL] [Abstract][Full Text] [Related]
19. The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study.
Feng X; Guo W; Wang Y; Li J; Zhao Y; Qu L; Yan X; Li J; Guo Q; Young KH; Bai O
Adv Ther; 2022 Jan; 39(1):532-543. PubMed ID: 34797505
[TBL] [Abstract][Full Text] [Related]
20. [Expression of GATA3 and bcl-11b in peripheral T-cell lymphoma and their clinical significance].
Wang YJ; Zhang HL; Li J; Bu P; Zhang F; Xi YF
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):904-909. PubMed ID: 34344074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
